{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T11:00:34Z","timestamp":1785236434741,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","contactlensjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contact Lens and Anterior Eye"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.clae.2024.102320","type":"journal-article","created":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T12:57:51Z","timestamp":1730206671000},"page":"102320","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Differential impact of combined therapy and monotherapy with 0.05% atropine eyedrops and dual focus contact lenses on choroid"],"prefix":"10.1016","volume":"48","author":[{"given":"Jiali","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqi","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhua","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7694-513X","authenticated-orcid":false,"given":"Yingying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clae.2024.102320_b0005","article-title":"Myopia - A 21st Century Public Health Issue","author":"Resnikoff","year":"2019603","journal-title":"Invest Ophthalmol vis Sci"},{"issue":"3","key":"10.1016\/j.clae.2024.102320_b0010","doi-asserted-by":"crossref","first-page":"510","DOI":"10.18240\/ijo.2022.03.21","article-title":"Scleral remodeling in myopia development","volume":"15","author":"Yu","year":"2022","journal-title":"Int J Ophthalmol"},{"issue":"8","key":"10.1016\/j.clae.2024.102320_b0015","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1167\/iovs.63.8.2","article-title":"Hypoxia-Induced Scleral HIF-2\u03b1 Upregulation Contributes to Rises in MMP-2 Expression and Myopia Development in Mice","volume":"63","author":"Wu","year":"2022","journal-title":"Invest Ophthalmol vis Sci"},{"issue":"30","key":"10.1016\/j.clae.2024.102320_b0020","doi-asserted-by":"crossref","first-page":"E7091","DOI":"10.1073\/pnas.1721443115","article-title":"Scleral hypoxia is a target for myopia control","volume":"115","author":"Wu","year":"2018","journal-title":"Proc Natl Acad Sci U S a"},{"issue":"1","key":"10.1016\/j.clae.2024.102320_b0025","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ophtha.2018.05.029","article-title":"Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control","volume":"126","author":"Yam","year":"2019","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.clae.2024.102320_b0030","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.clae.2017.09.010","article-title":"Choroidal thickness and axial length changes in myopic children treated with orthokeratology","volume":"40","author":"Li","year":"2017","journal-title":"Cont Lens Anterior Eye"},{"issue":"2","key":"10.1016\/j.clae.2024.102320_b0035","doi-asserted-by":"crossref","first-page":"198","DOI":"10.7150\/ijms.30118","article-title":"Retardation of Myopia Progression by Multifocal Soft Contact Lenses","volume":"16","author":"Zhu","year":"2019","journal-title":"Int J Med Sci"},{"issue":"8","key":"10.1016\/j.clae.2024.102320_b0040","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/OPX.0000000000001410","article-title":"A 3-year Randomized Clinical Trial of MiSight Lenses for Myopia Control","volume":"96","author":"Chamberlain","year":"2019","journal-title":"Optom vis Sci"},{"issue":"1","key":"10.1016\/j.clae.2024.102320_b0045","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s40662-023-00356-z","article-title":"Defocus incorporated multiple segments (DIMS) spectacle lenses increase the choroidal thickness: a two-year randomized clinical trial","volume":"10","author":"Chun","year":"2023","journal-title":"Eye vis (lond)"},{"key":"10.1016\/j.clae.2024.102320_b0050","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ajo.2021.12.014","article-title":"The Association of Choroidal Thickening by Atropine With Treatment Effects for Myopia: Two-Year Clinical Trial of the Low-concentration Atropine for Myopia Progression (LAMP) Study","volume":"237","author":"Yam","year":"2022","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.clae.2024.102320_b0055","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/opo.12722","article-title":"One-year results of 0.01% atropine with orthokeratology (AOK) study: a randomised clinical trial","volume":"40","author":"Tan","year":"2020","journal-title":"Ophthalmic Physiol Opt"},{"issue":"5","key":"10.1016\/j.clae.2024.102320_b0060","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1080\/08164622.2021.1943318","article-title":"Adjunctive effects of orthokeratology and atropine 0.01% eye drops on slowing the progression of myopia","volume":"105","author":"Zhou","year":"2022","journal-title":"Clin Exp Optom"},{"issue":"1","key":"10.1016\/j.clae.2024.102320_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.clae.2022.101723","article-title":"Combined 0.01% atropine with orthokeratology in childhood myopia control (AOK) study: A 2-year randomized clinical trial","volume":"46","author":"Tan","year":"2023","journal-title":"Cont Lens Anterior Eye"},{"issue":"2","key":"10.1016\/j.clae.2024.102320_b0070","doi-asserted-by":"crossref","first-page":"e0281816","DOI":"10.1371\/journal.pone.0281816","article-title":"A comparison of myopia control in European children and adolescents with defocus incorporated multiple segments (DIMS) spectacles, atropine, and combined DIMS\/atropine","volume":"18","author":"Nucci","year":"2023","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.clae.2024.102320_b0075","doi-asserted-by":"crossref","first-page":"22311","DOI":"10.1038\/s41598-022-25599-z","article-title":"Synergistic effects of defocus-incorporated multiple segments and atropine in slowing the progression of myopia","volume":"12","author":"Huang","year":"2022","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.clae.2024.102320_b0080","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.ophtha.2019.12.011","article-title":"Two-Year Clinical Trial of the Low-Concentration Atropine for Myopia Progression (LAMP) Study: Phase 2 Report","volume":"127","author":"Yam","year":"2020","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.clae.2024.102320_b0085","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ophtha.2021.10.002","article-title":"Three-Year Clinical Trial of Low-Concentration Atropine for Myopia Progression (LAMP) Study: Continued Versus Washout: Phase 3 Report","volume":"129","author":"Yam","year":"2022","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.clae.2024.102320_b0090","doi-asserted-by":"crossref","first-page":"e454","DOI":"10.1111\/aos.13866","article-title":"Change in subfoveal choroidal thickness secondary to orthokeratology and its cessation: a predictor for the change in axial length","volume":"97","author":"Li","year":"2019","journal-title":"Acta Ophthalmol"},{"issue":"5","key":"10.1016\/j.clae.2024.102320_b0095","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1444-0938.2012.00749.x","article-title":"Macular thickness and volume of myopic eyes measured using spectral-domain optical coherence tomography","volume":"95","author":"Hwang","year":"2012","journal-title":"Clin Exp Optom"},{"issue":"13","key":"10.1016\/j.clae.2024.102320_b0100","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11133833","article-title":"Changes in the Choroidal Thickness of Children Wearing MiSight to Control Myopia","volume":"11","author":"Prieto-Garrido","year":"2022","journal-title":"J Clin Med"},{"issue":"9","key":"10.1016\/j.clae.2024.102320_b0105","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1007\/s10792-021-01855-5","article-title":"Changes in subfoveal choroidal thickness in myopic children with 0.01% atropine, orthokeratology, or their combination","volume":"41","author":"Hao","year":"2021","journal-title":"Int Ophthalmol"},{"issue":"3","key":"10.1016\/j.clae.2024.102320_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.clae.2020.06.006","article-title":"Short-term effects of atropine combined with orthokeratology (ACO) on choroidal thickness","volume":"44","author":"Zhao","year":"2021","journal-title":"Cont Lens Anterior Eye"},{"issue":"6","key":"10.1016\/j.clae.2024.102320_b0115","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1167\/iovs.64.6.4","article-title":"IMI-The Dynamic Choroid: New Insights, Challenges, and Potential Significance for Human Myopia","volume":"64","author":"Ostrin","year":"2023","journal-title":"Invest Ophthalmol vis Sci"},{"key":"10.1016\/j.clae.2024.102320_b0120","doi-asserted-by":"crossref","first-page":"4782536","DOI":"10.1155\/2019\/4782536","article-title":"Short-Term Effect of Low-Dose Atropine and Hyperopic Defocus on Choroidal Thickness and Axial Length in Young Myopic Adults","volume":"2019","author":"Sander","year":"2019","journal-title":"J Ophthalmol"},{"issue":"3","key":"10.1016\/j.clae.2024.102320_b0125","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.ophtha.2014.09.028","article-title":"Myopia control during orthokeratology lens wear in children using a novel study design","volume":"122","author":"Swarbrick","year":"2015","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.clae.2024.102320_b0130","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00417-022-05794-4","article-title":"Low-intensity red-light therapy in slowing myopic progression and the rebound effect after its cessation in Chinese children: a randomized controlled trial","volume":"261","author":"Chen","year":"2023","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"10.1016\/j.clae.2024.102320_b0135","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41598-016-0002-7","article-title":"Nitric Oxide (NO) Mediates the Inhibition of Form-Deprivation Myopia by Atropine in Chicks","volume":"6","author":"Carr","year":"2016","journal-title":"Sci Rep"},{"issue":"22","key":"10.1016\/j.clae.2024.102320_b0140","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1111\/bph.15629","article-title":"Insights into the mechanism by which atropine inhibits myopia: evidence against cholinergic hyperactivity and modulation of dopamine release","volume":"178","author":"Thomson","year":"2021","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.clae.2024.102320_b0145","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.exer.2006.01.029","article-title":"Inhibiting the transient choroidal thickening response using the nitric oxide synthase inhibitor l-NAME prevents the ameliorative effects of visual experience on ocular growth in two different visual paradigms","volume":"83","author":"Nickla","year":"2006","journal-title":"Exp Eye Res"},{"issue":"6","key":"10.1016\/j.clae.2024.102320_b0150","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1159\/000525744","article-title":"Mechanism of Myopic Defocus or Atropine for Myopia Control: Different or Similar Ways?","volume":"65","author":"Sun","year":"2022","journal-title":"Ophthalmic Res"},{"issue":"24","key":"10.1016\/j.clae.2024.102320_b0155","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11247498","article-title":"Axial Length Shortening and Choroid Thickening in Myopic Adults Treated with Repeated Low-Level Red Light","volume":"11","author":"Liu","year":"2022","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.clae.2024.102320_b0160","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40662-023-00345-2","article-title":"Choroidal vasculature act as predictive biomarkers of long-term ocular elongation in myopic children treated with orthokeratology: a prospective cohort study","volume":"10","author":"Wu","year":"2023","journal-title":"Eye vis (lond)"},{"issue":"1","key":"10.1016\/j.clae.2024.102320_b0165","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000510715","article-title":"Choroidal Thickness Changes after Orthokeratology Lens Wearing in Young Adults with Myopia","volume":"64","author":"Lee","year":"2021","journal-title":"Ophthalmic Res"},{"issue":"5","key":"10.1016\/j.clae.2024.102320_b0170","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/OPX.0000000000000573","article-title":"Choroidal Thickness and Peripheral Myopic Defocus during Orthokeratology","volume":"92","author":"Gardner","year":"2015","journal-title":"Optom vis Sci"}],"container-title":["Contact Lens and Anterior Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367048424002133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367048424002133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T22:53:19Z","timestamp":1736290399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1367048424002133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1367048424002133"],"URL":"https:\/\/doi.org\/10.1016\/j.clae.2024.102320","relation":{},"ISSN":["1367-0484"],"issn-type":[{"value":"1367-0484","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential impact of combined therapy and monotherapy with 0.05% atropine eyedrops and dual focus contact lenses on choroid","name":"articletitle","label":"Article Title"},{"value":"Contact Lens and Anterior Eye","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clae.2024.102320","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 British Contact Lens Association. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102320"}}